Peptide Industry intermediate
Peptide Regulatory Landscape
Global regulatory frameworks governing peptide drug approval and marketing.
By Encyclopeptide Editorial | 1 min read
regulation fda ema compliance
Overview
Peptide drugs are regulated as small molecule drugs in most jurisdictions, with specific guidelines for synthesis and characterization.
Regulatory Bodies
- FDA: US approval via NDA or ANDA pathway
- EMA: European approval via centralized procedure
- PMDA: Japanese approval requirements
- NMPA: Chinese regulatory framework
Key Guidelines
- ICH Q7: GMP for active pharmaceutical ingredients
- ICH Q3: Impurity guidelines
- FDA ANDA pathway for peptide generics
- EMA guideline on similar biological products
Challenges
Defining peptide similarity for generic approval and establishing bioequivalence for complex formulations remain regulatory challenges.
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Regulatory Landscape with interactive quizzes on Wikipept.
Take a Quiz on Wikipept